| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/35176486_HAS_TOPIC_C0035363> <https://research.tib.eu/covid-19/entity/35176486_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/35176486_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/35176486_HAS_TOPIC_C2985546> <https://research.tib.eu/covid-19/entity/35176486_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/35176486_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/35176486_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/35176486_HAS_TOPIC_C5422688> <https://research.tib.eu/covid-19/entity/35176486_HAS_TOPIC_C5422689> <https://research.tib.eu/covid-19/entity/35176486_HAS_TOPIC_C5435277> <https://research.tib.eu/covid-19/entity/35176486_HAS_TOPIC_C5435278>
?:authorAffiliation	[\'Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan. Electronic address: y_kakinoki@ach.hokkaido.jp.\', \'Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan.\', \'Asahikawa City Health Center, Asahikawa, Japan.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Asari_Go> <https://research.tib.eu/covid-19/entity/Ichikawa_Takaya> <https://research.tib.eu/covid-19/entity/Kakinoki_Yasutaka> <https://research.tib.eu/covid-19/entity/Kukita_Shin> <https://research.tib.eu/covid-19/entity/Kuroda_Shohei> <https://research.tib.eu/covid-19/entity/Nagashima_Yuuki> <https://research.tib.eu/covid-19/entity/Nakamura_Ai> <https://research.tib.eu/covid-19/entity/Saito_Seisuke> <https://research.tib.eu/covid-19/entity/Sakagami_Hidemitsu> <https://research.tib.eu/covid-19/entity/Suzuki_Keiko> <https://research.tib.eu/covid-19/entity/Suzuki_Naoki> <https://research.tib.eu/covid-19/entity/Suzuki_Satoshi> <https://research.tib.eu/covid-19/entity/Takahashi_Kae> <https://research.tib.eu/covid-19/entity/Tanino_Yoko> <https://research.tib.eu/covid-19/entity/Uehara_Akito> <https://research.tib.eu/covid-19/entity/Yamada_Kazuki>
?:doi	S1201-9712(22)00076-510.1016/j.ijid.2022.01.067
?:doi	<https://research.tib.eu/covid-19/entity/S1201-9712%2822%2900076-510.1016/j.ijid.2022.01.067>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of	<https://research.tib.eu/covid-19/entity/35176486>
?:pmid	<https://research.tib.eu/covid-19/entity/35176486>
?:pmid	35176486
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C1830377_PROCESS_OF_C0030705>
?:title	Impact of Antibody Cocktail Therapy Combined with Casirivimab and Imdevimab on Clinical Outcome for patients with COVID-19 in A Real-Life Setting: A Single Institute Analysis.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/35176486>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/35176486>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all